Nano X Imaging Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $17 Price Target
Nano X Imaging Analyst Ratings
Nano X Imaging Analyst Ratings
Analyst Reiterates Overweight Rating on Nano-X Imaging Post NVIDIA Investment News
Nano X Imaging Analyst Ratings
Nano X Imaging Analyst Ratings
Nano X Imaging Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
Nano X Imaging Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
Nano X Imaging Analyst Ratings
Nano X Imaging Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
Nano X Imaging Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
Nano X Imaging Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Nano X Imaging, Maintains $30 Price Target
Watching Nano-X Imaging; Hearing Cantor Fitzgerald Says Co Won A Large Hospital Contract In Europe, Notably, ARC System At CHU University Hospital In Marrakech, Reiterating Its Overweight Rating And $30 Price Target
Cantor Fitzgerald Adjusts Nano-X Imaging Price Target to $30 From $21, Maintains Overweight Rating
No Data